Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018

Matthew Taylor Initiated (ABT) at Buy and Held Target at $80 on, Oct 16th, 2018

Matthew Taylor of Barclays, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $80 on, Oct 16th, 2018.

Matthew has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Matthew


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $80 on, Thursday, October 11th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $77 on, Monday, September 24th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $72 on, Thursday, July 19th, 2018